Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000442609 | SCV000534121 | likely benign | not specified | 2016-11-22 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV000562125 | SCV000664997 | likely benign | Hereditary cancer-predisposing syndrome | 2016-02-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000934156 | SCV001079873 | likely benign | Hereditary breast ovarian cancer syndrome | 2024-05-21 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000562125 | SCV004360138 | likely benign | Hereditary cancer-predisposing syndrome | 2021-07-26 | criteria provided, single submitter | clinical testing | |
Brotman Baty Institute, |
RCV001072963 | SCV001238435 | not provided | Breast-ovarian cancer, familial, susceptibility to, 1 | no assertion provided | in vitro |